High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast can

High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast can

Item

http://www.wikidata.org/entity/Q40554971

Q40554971

about

Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice Potential Effects of Pomegranate on Lipid Peroxidation and Pro-inflammatory Changes in Daunorubicin-induced Cardiotoxicity in Rats

P2860

Q27345163-A52910A9-0725-4835-9A8D-FA51D14C2ADF Q37050999-D68B6748-39B2-4693-8520-DECA68268A79

P2860

High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast can

Item

http://www.wikidata.org/entity/Q40554971

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

High-dose epirubicin, preceded ...... -risk stage II-IIIA breast can

@en

type

Item

label

High-dose epirubicin, preceded ...... -risk stage II-IIIA breast can

@en

prefLabel

High-dose epirubicin, preceded ...... -risk stage II-IIIA breast can

@en

P1476

High-dose epirubicin, preceded ...... -risk stage II-IIIA breast can

@en

P2093

A Zaniboni

http://www.w3.org/2001/XMLSchema#string

E Ferrari

http://www.w3.org/2001/XMLSchema#string

G Rosti

http://www.w3.org/2001/XMLSchema#string

L Zornetta

http://www.w3.org/2001/XMLSchema#string

M Baioni

http://www.w3.org/2001/XMLSchema#string

M Ballardini

http://www.w3.org/2001/XMLSchema#string

M Marangolo

http://www.w3.org/2001/XMLSchema#string

M R Minzi

http://www.w3.org/2001/XMLSchema#string

U De Giorgi

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study

Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial.

Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.

Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.

American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.

Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer.

Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer.

Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer. The Epirubicin High Dose (HEPI 010) Study Group.

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.

Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice.

P2888

sj.bmt.1704125

P304

251-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1704125

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6601611

http://www.w3.org/2001/XMLSchema#string

P6179

1044786310

http://www.w3.org/2001/XMLSchema#string

P698

12858195

http://www.w3.org/2001/XMLSchema#string

High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast can

about

P2860

P2860

High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II-IIIA breast can

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P5875

P6179

P698